尽管在手术后实施了多模式治疗,胶质母细胞瘤(GBM)仍然是一种无法治愈的疾病,在神经肿瘤学中构成重大挑战。在这种临床环境中,局部治疗(LT),一个发展中的范式,随着时间的推移,由于其克服GBM常规治疗选择的缺点的潜力而受到了极大的关注。本综述旨在追溯历史发展,突出当代的进步,并提供对LT在GBM管理中的未来视野的见解。符合系统审查和荟萃分析方案标准的首选报告项目,我们对LT在GBM管理中的作用进行了系统综述.共发现2,467篇潜在相关文章,删除副本后,通过标题和摘要筛选了2,007项研究(科恩κ系数=0.92)。总的来说,有15、10和6项临床研究探讨了术中局部治疗方式的临床效率,局部放疗和局部免疫治疗,分别。在80%的病例中,GBM复发发生在辐射场的2厘米范围内,强调局部因素对复发的显著影响。这突出了对LT战略的迫切需要。总的来说,因此,近几十年来,三个主要原因导致了许多LT解决方案的发展:i)肿瘤内植入物允许绕过血脑屏障,导致有限的全身毒性;ii)LT促进手术和标准治疗之间的桥接治疗;和iii)考虑到GBM的复杂性,通过对各种元素具有特异性的配体靶向肿瘤微环境的多种成分可能在治疗中具有协同作用。考虑到GBM的时空异质性,在精准医学时代,通过联合治疗策略可以显著改善疾病预后.
Despite the implementation of multimodal treatments after surgery, glioblastoma (GBM) remains an incurable disease, posing a significant challenge in neuro-oncology. In this clinical setting, local therapy (LT), a developing paradigm, has received significant interest over time due to its potential to overcome the drawbacks of conventional therapy options for GBM. The present
review aimed to trace the historical development, highlight contemporary advances and provide insights into the future horizons of LT in GBM management. In compliance with the Preferred Reporting Items for Systematic
Review and Meta-Analysis Protocols criteria, a systematic
review of the literature on the role of LT in GBM management was conducted. A total of 2,467 potentially relevant articles were found and, after removal of duplicates, 2,007 studies were screened by title and abstract (Cohen\'s κ coefficient=0.92). Overall, it emerged that 15, 10 and 6 clinical studies explored the clinical efficiency of intraoperative local treatment modalities, local radiotherapy and local immunotherapy, respectively. GBM recurrences occur within 2 cm of the radiation field in 80% of cases, emphasizing the significant influence of local factors on recurrence. This highlights the urgent requirement for LT strategies. In total, three primary reasons have thus led to the development of numerous LT solutions in recent decades: i) Intratumoral implants allow the blood-brain barrier to be bypassed, resulting in limited systemic toxicity; ii) LT facilitates bridging therapy between surgery and standard treatments; and iii) given the complexity of GBM, targeting multiple components of the tumor microenvironment through ligands specific to various elements could have a synergistic effect in treatments. Considering the spatial and temporal heterogeneity of GBM, the disease prognosis could be significantly improved by a combination of therapeutic strategies in the era of precision medicine.